- Email: [email protected]
4908380 Pharmaceutical compositions
New Patents
ter in order to remove any substances having a molecular weight of about 5000. The extract is then finally concentrated under vacuum to yield a liquid concentrate or a dry residue.
xv
A pharmaceutical preparation for prophylaxis and treatment of alcoholism comprises an active principle which is nicotinic acid lithium salt semihydrate of the formula: See Patent for Chemical Structure and a pharmaceutically acceptable vehicle.
4908214 PHARMACEUTICAL TABLET FOR THE TREATMENT OF URAEMIA Jean-Mar Bobee, Christia Melin, Verrires le Buisson, France assigned to Synthelabo A tablet constituted by (1) a core comprising a mixture of salts formed by a basic alpha-amino acids and alpha-keto analogues of branchedchain essential amino acids and (2) a gastroresistant or gastrosoluble coating.
4908365 BENZHYDRYL OXYETHYLPIPERAZINE DERIVATIVES, PROCESSES FORTHEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT Andre Merour Jcan-Yves Buzas. Roland Ollivier, 91570 Bievres, France The present invention relates to benzhydryloxyethylpiperazine derivatives of the formula: See Patent Jor Chemical Structure It also relates to processes for the preparation of the said derivatives and pharmaceutical compositions in which they are present. The said derivatives have an antihistaminic activity without a sedative component.
4908374 PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF ALCOHOLISM Valentin I Kresjun, Vadim Aryaev, Georgy Rudenko, Andrei G Vrublevsky, Fedor I Kostev, Roman Maximovich, Roman Y Maximovich, Odessa, Union Of Soviet Socialist Republics
4908380 PHARMACEUTICAL COMPOSITIONS Andrew G Brewster, George R Brown, Michael J Smithers, Macclesfield, United Kingdom assigned to Imperial Chemical Industries plc The invention concerns novel pharmaceutical compositions containing a 4(Z) 6 (2,4 diphenyli,3 dioxan-5-yl)-alkenoic acid which antagonizes one or more of the actions of thromboxane A2, together with a compound which inhibits the synthesis of thromboxane A2. The compositios are useful as medicines in treating a variety of diseases or medical conditions in which thromboxane A2 and/or other prostanoid contractile substances are involved.
4908385 ALPHA-HALOGENATED DICARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE Jacob Bar-Tana, Yoelit Migron, Jochanan Blum, Bruno Dreckmann, Johannes Pill, Jerusalem, Israel assigned to Epis S A The present invention provides pharmaceutical compositions containing at least one alphahalogenated dicarboxylic acid of the general formula: See Patent for Chemical Structure (I) wherein Hal is a chlorine, bromine or fluorine atom, R is a hydrogen atom or Hal and m is a number of from 4 to 16, and/or at least one pharmacologically acceptable salt, ester or amide thereof. The present invention also provides new compounds of general formula (I) but in which m is a number of from 8 to 16 and processes for the preparation thereof.
ter in order to remove any substances having a molecular weight of about 5000. The extract is then finally concentrated under vacuum to yield a liquid concentrate or a dry residue.
xv
A pharmaceutical preparation for prophylaxis and treatment of alcoholism comprises an active principle which is nicotinic acid lithium salt semihydrate of the formula: See Patent for Chemical Structure and a pharmaceutically acceptable vehicle.
4908214 PHARMACEUTICAL TABLET FOR THE TREATMENT OF URAEMIA Jean-Mar Bobee, Christia Melin, Verrires le Buisson, France assigned to Synthelabo A tablet constituted by (1) a core comprising a mixture of salts formed by a basic alpha-amino acids and alpha-keto analogues of branchedchain essential amino acids and (2) a gastroresistant or gastrosoluble coating.
4908365 BENZHYDRYL OXYETHYLPIPERAZINE DERIVATIVES, PROCESSES FORTHEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT Andre Merour Jcan-Yves Buzas. Roland Ollivier, 91570 Bievres, France The present invention relates to benzhydryloxyethylpiperazine derivatives of the formula: See Patent Jor Chemical Structure It also relates to processes for the preparation of the said derivatives and pharmaceutical compositions in which they are present. The said derivatives have an antihistaminic activity without a sedative component.
4908374 PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF ALCOHOLISM Valentin I Kresjun, Vadim Aryaev, Georgy Rudenko, Andrei G Vrublevsky, Fedor I Kostev, Roman Maximovich, Roman Y Maximovich, Odessa, Union Of Soviet Socialist Republics
4908380 PHARMACEUTICAL COMPOSITIONS Andrew G Brewster, George R Brown, Michael J Smithers, Macclesfield, United Kingdom assigned to Imperial Chemical Industries plc The invention concerns novel pharmaceutical compositions containing a 4(Z) 6 (2,4 diphenyli,3 dioxan-5-yl)-alkenoic acid which antagonizes one or more of the actions of thromboxane A2, together with a compound which inhibits the synthesis of thromboxane A2. The compositios are useful as medicines in treating a variety of diseases or medical conditions in which thromboxane A2 and/or other prostanoid contractile substances are involved.
4908385 ALPHA-HALOGENATED DICARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE Jacob Bar-Tana, Yoelit Migron, Jochanan Blum, Bruno Dreckmann, Johannes Pill, Jerusalem, Israel assigned to Epis S A The present invention provides pharmaceutical compositions containing at least one alphahalogenated dicarboxylic acid of the general formula: See Patent for Chemical Structure (I) wherein Hal is a chlorine, bromine or fluorine atom, R is a hydrogen atom or Hal and m is a number of from 4 to 16, and/or at least one pharmacologically acceptable salt, ester or amide thereof. The present invention also provides new compounds of general formula (I) but in which m is a number of from 8 to 16 and processes for the preparation thereof.